Gunes Dorukhan Cavusoglu

5PUBLICATIONS
14CO-AUTHORS
ChemotherapyPredictive and prognostic markersHaematologyAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 15, 2026
EZH2 Expression and Clinical Outcomes in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: A Real-World Retrospective Cohort Study.

|Aug 27, 2026
Clinicopathological Features, Tumor Localization and Treatment Outcomes in Paraganglioma: A Single-Center Medical Oncology Cohort.

|Jan 10, 2026
Inflammation-Related Parameters in Lung Cancer Patients Followed in the Intensive Care Unit.

Burcu Tunay, Omer Fatih Olmez, Ahmet Bilici

|Jun 22, 2022
Do neutrophil-lymphocyte ratio and platelet-lymphocyte ratio have a role in determining mortality in intensive care patients undergoing plasmapheresis? Single-center experience.

Sevil Sadri, Gunes Cavusoglu, Burcu Tunay

|Jul 20, 2021
Rare side effect caused by atezolizumab, an immune checkpoint inhibitor: Cold agglutinin disease.

Ozgur Acikgoz, Ayberk Bayramgil, Gunes Cavusoglu

Pageof 1

Frequent Collaborators

2 joint publications

Ayberk Bayramgil

2 joint publications

Hatice Asoglu

2 joint publications

Abdurrahman Aykut

2 joint publications

Yasemin Aydınalp